BLI 400

Drug Profile

BLI 400

Alternative Names: BLI400; BLI400 Laxative

Latest Information Update: 08 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Braintree Laboratories
  • Class Laxatives
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Constipation

Most Recent Events

  • 01 Jun 2017 Braintree Laboratories completes a phase III trials for Constipation (In adults) in USA (NCT02819297)
  • 01 Jun 2016 Braintree Laboratories initiates two phase III trials for Constipation (In adults) in USA (PO) (NCT02819297; NCT02819310)
  • 01 Apr 2016 Braintree Laboratories completes a phase II trial in Constipation (In adolescents) in USA (PO) (NCT02665728)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top